Quantum Computing Inc.
Business
Quantum Computing Inc. develops and delivers integrated photonics and non-linear quantum optics machines for quantum computing, reservoir computing, remote sensing, imaging and cybersecurity applications. Its main offerings include the Entropy Quantum Computer (EQC) with Qatalyst full‑stack software, Thin Film Lithium Niobate (TFLN) optical chips and foundry services, a Reservoir Computer edge device, LiDAR and a Quantum Photonic Vibrometer, and a quantum authentication system. Key business lines comprise EQC systems, TFLN chip manufacturing/foundry, sensing/imaging products, quantum networks/authentication, and Quantum Solutions professional services. The company serves commercial and government customers via cloud access, on‑premises installations, and chip foundry distribution channels.
Summary from filing dated 2025-03-20
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 682,000 | 373,000 | 358,000 | 135,648 | — | |
| Cost of revenue | 615,000 | 261,000 | 196,000 | 60,934 | — | |
| Gross profit | 67,000 | 112,000 | 162,000 | 74,714 | — | |
| Research and development | 20 | 11 | 9 | 5 | 3 | |
| Sales and marketing | 3 | 2 | 2 | — | — | |
| General and administrative | 27 | 13 | 16 | — | — | |
| Total operating expenses | 51 | 26 | 26 | 37 | 17 | |
| Loss from operations | −51 | −26 | −26 | −37 | −17 | |
| Interest and other income, net | 21 | 423,000 | 295,000 | — | — | |
| Interest expense | −65,000 | −2 | −2 | — | — | |
| Change in fair value of derivative liability | 12 | −41 | 528,000 | — | — | |
| Loss before income tax provision | −19 | −69 | −27 | — | — | |
| Income tax provision | — | — | — | — | — | |
| Net Loss | −19 | −69 | −27 | −39 | −28 | |
| Less: Series A convertible preferred stock dividends | — | — | 861,000 | — | — | |
| Net loss attributable to common stockholders | −19 | −69 | −28 | — | — | |
| Unrealized gain on available-for-sale debt securities (net of tax) | 905,000 | — | — | — | — | |
| Total comprehensive income (loss) | −18 | −69 | −28 | — | — | |
| Basic (in Dollars per share) | −0.11 | −0.73 | −0.42 | −0.69 | −0.96 | |
| Diluted (in Dollars per share) | −0.11 | −0.73 | −0.42 | −0.52 | −0.96 | |
| Basic (in Shares) | 164,492 | 93,881 | 66,611 | 56 | 29 | |
| Diluted (in Shares) | 164,492 | 93,881 | 66,611 | 74 | 29 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 738 | 79 | 2 | 5 | 17 | |
| Accounts receivable, net | 519,000 | 27,000 | 65,000 | 12,774 | — | |
| Inventory | 352,000 | 18,000 | 73,000 | — | — | |
| Loans receivable, net | — | — | — | — | — | |
| Short Term Investments | 379 | — | — | — | — | |
| Accrued interest receivable | 4 | — | — | — | — | |
| Prepaid expenses and other current assets | 12 | 161,000 | 180,000 | — | — | |
| Total current assets | 1,134 | 79 | 3 | 6 | 17 | |
| Property and equipment, net | 13 | 8 | 3 | 975,169 | 41,348 | |
| Operating lease right-of-use assets | 2 | 2 | 1 | 1 | 18,084 | |
| Intangible assets, net | 7 | 9 | 12 | 22 | — | |
| Goodwill | 56 | 56 | 56 | 59 | — | |
| Long-term investments | 403 | — | — | — | — | |
| Accrued interest receivable - long term | 5 | — | — | — | — | |
| Other non-current assets | 131,000 | 129,000 | 129,000 | 83 | 21,193 | |
| Total assets | 1,619 | 154 | 74 | 89 | 17 | |
| Accounts payable | 778,000 | 1 | 1 | 871,887 | 464,870 | |
| Accrued expenses | 9 | 2 | 639,000 | 4 | 478,505 | |
| Deferred revenue | 395,000 | 79,000 | — | — | — | |
| Other current liabilities | 766,000 | 974,000 | 786,000 | 131,849 | 3,385 | |
| Total current liabilities | 11 | 5 | 5 | 5 | 1 | |
| Derivative liability | 8 | 41 | — | — | — | |
| Operating lease liabilities | 2 | 1 | 840,000 | 1 | — | |
| Total liabilities | 21 | 46 | 6 | 14 | 1 | |
| Contingencies (see Note 10) | — | — | — | — | — | |
| Preferred stock, $0.0001 par value, 1,550 shares Series A Preferred authorized; no shares issued and outstanding as of December 31, 2025 and 2024, respectively; 3,080 thousand shares of Series B Preferred Stock authorized; no shares issued and outstanding as of December 31, 2025 and 2024, respectively | — | — | — | 150 | 154 | |
| Common stock, $0.0001 par value, 250,000 thousand shares authorized; 224,165 and 129,012 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 22,000 | 13,000 | 8,000 | 5,596 | 2,916 | |
| Additional paid-in capital | 1,816 | 308 | 201 | 151 | 67 | |
| Accumulated deficit | −219 | −200 | −132 | −120 | −81 | |
| Accumulated other comprehensive income | 905,000 | — | — | — | — | |
| Total stockholders equity | 1,598 | 107 | 69 | 65 | 16 | |
| Total liabilities and mezzanine and stockholders equity | 1,619 | 154 | 74 | 89 | 17 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and intangibles amortization | 4 | 4 | 3 | 3 | 8,998 | |
| Amortization of issuance costs | — | 2 | 925,000 | — | — | |
| Change in value of derivative | — | −666,000 | — | — | — | |
| Provision for credit losses | — | 279,000 | 279,000 | — | — | |
| Amortization of operating lease right-of-use assets | 540,000 | 294,000 | 222,000 | — | — | |
| Stock-based compensation expense | 9 | 6 | 4 | 14 | 10 | |
| Stock-based compensation expense for services | 18,000 | 23,000 | 284,000 | — | — | |
| Accounts receivable | −492,000 | 38,000 | −52,000 | −12,774 | — | |
| Inventory | −334,000 | 55,000 | −70,000 | — | — | |
| Accrued interest receivable | −8 | — | — | — | — | |
| Prepaid expenses and other current assets | −12 | 16,000 | −110,000 | — | — | |
| Other non-current assets | −2,000 | — | −69,000 | −1 | — | |
| Accounts payable | −594,000 | −90,000 | 596,000 | 218,574 | 98,164 | |
| Deferred revenue | 316,000 | 79,000 | — | — | — | |
| Accrued expenses and other current liabilities | 8 | 362,000 | −112,000 | — | — | |
| Operating lease liabilities | −412,000 | −236,000 | −241,000 | 1 | — | |
| Net cash used in operating activities | −30 | −16 | −18 | −17 | −7 | |
| Purchase of property and equipment | −7 | −6 | −2 | −869,687 | −19,391 | |
| Issuance of loan receivable | — | — | −500,000 | — | — | |
| Purchases of available-for-sale debt securities | −1,198 | — | — | — | — | |
| Proceeds from sales of available-for-sale debt securities | 376 | — | — | — | — | |
| Proceeds from maturities of available-for-sale debt securities | 40 | — | — | — | — | |
| Other recognized losses (gains) | −7,000 | — | — | — | — | |
| Net cash used in investing activities | −788 | −6 | −3 | −2 | −22,500 | |
| Proceeds raised from financial liabilities, net of issuance costs | — | 7 | — | — | — | |
| Payments of financial liabilities, net of interest | — | −10 | −6 | — | — | |
| Series A Preferred stock dividend payments | — | −215,000 | −865,000 | — | — | |
| Repurchase of Series A preferred stock | — | −4 | — | — | — | |
| Proceeds from stock issuance related to ATM facility | — | — | — | — | — | |
| Net proceeds from exercise of warrants | 2 | — | — | — | — | |
| Net proceeds from issuance of common stock | 1,475 | 107 | 25 | — | 9 | |
| Net cash provided by financing activities | 1,478 | 99 | 18 | 8 | 8 | |
| Net increase (decrease) in cash | 659 | 77 | −3 | −11 | — | |
| Cash paid for interest | — | 268,000 | 813,000 | — | — | |
| Fair value of derivative liability reclassed to additional paid-in capital due to exercise of warrants | 21 | — | — | — | — | |
| Issuance of stock expensed from 2024, awarded in 2025 | 2 | — | — | 83 | −2 | |
| Leased assets obtained in exchange for new operating lease liabilities | 1 | 765,000 | — | — | −18,084 | |
| Reclassification of Series A preferred stock to mezzanine equity | — | 8 | — | — | — | |
| Valuation of derivative associated with convertible financial liability | — | 666,000 | — | — | — | |
| Conversion of Series A preferred to common stock | — | 4 | — | — | — |